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The Keap1-Nrf2 system is an evolutionarily conserved defense mechanism against oxidative and xenobiotic stress. Besides the
exogenous stress response, Nrf2 has been found to regulate numerous cellular functions, including protein turnover and glucose
metabolism; however, the evolutionary origins of these functions remain unknown. In the present study,we searched for novel target
genes associated with the zebrafish Nrf2 to answer this question. A microarray analysis of zebrafish embryos that overexpressed
Nrf2 revealed that 115 candidate genes were targets of Nrf2, including genes encoding proteasome subunits and enzymes involved
in glucose metabolism. A real-time quantitative PCR suggested that the expression of 3 proteasome subunits (psma3, psma5, and
psmb7) and 2 enzymes involved in glucose metabolism (pgd and fbp1a) were regulated by zebrafish Nrf2. We thus next examined
the upregulation of these genes by an Nrf2 activator, diethyl maleate, using Nrf2 mutant zebrafish larvae. The results of real-time
quantitative PCR and whole-mount in situ hybridization showed that all of these 5 genes were upregulated by diethyl maleate
treatment in an Nrf2-dependent manner, especially in the liver. These findings implied that the Nrf2-mediated regulation of the
proteasome subunits and glucose metabolism is evolutionarily conserved among vertebrates.
1. Introduction
The Keap1-Nrf2 system is a mechanism that protects cells
against xenobiotic and oxidative stress. Under conditions of
stress, transcription factor Nrf2 transactivates a wide array of
genes, which perform a range of functions, including (but not
limited to) the encoding of antioxidant proteins, glutathione-
conjugating enzymes, and xenobiotic transporters. This con-
fers an inducible defense against stressors [1, 2]. Although
these genes have been extensively studied as Nrf2 targets,
there is increasing evidences to show that Nrf2 activates a
wider gene set than was initially considered [3]. Nrf2 regu-
lates the protein turnover by inducing proteasome subunits
to confer protective effects against chronic diseases [4] and
modifies cellular metabolic processes, for example, the pen-
tose phosphate pathway, which provides NADPH and purine
nucleotides that are essential for the redox homeostasis and
cellular proliferation [5, 6]. Because of thismultifunctionality,
Nrf2 research has become an emerging topic in the medical
field [7, 8].
The zebrafish has become a popular model vertebrate in
basic medical science [9, 10]. Although it is convenient to
use lower vertebrate models for medical research, there is
always some concern as towhether the findings are applicable
to human medicine. We have investigated the Keap1-Nrf2
system using the zebrafish as a model and revealed that the
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regulation of the system is based on a similar molecular
mechanism to mammals [11–15]. Moreover, an analysis of
the Nrf2 mutant zebrafish strain, nrf2afh318, revealed that the
protective role against oxidative and xenobiotic stress was
conserved in the zebrafish [16, 17]. The lineup of the target
genes in the zebrafish, which provides the defense function,
is also being clarified from recent studies [18]. Our previous
study [19] and the study of Hahn et al. [20] reported the
performance of microarray analyses using zebrafish larvae
treated with potent Nrf2 inducers, diethyl maleate (DEM)
and tert-butylhydroquinone (tBHQ), respectively, and found
that canonical Nrf2 targets, such as detoxification and antiox-
idative enzymes were conserved in zebrafish. However, it
is still unclear whether the Nrf2-mediated regulation of
cellular pathways other than antioxidation and detoxification,
for example, protein turnover and glucose metabolism, is
conserved among vertebrates or whether it is only present in
higher vertebrates.
In the present study, we searched for novel target genes
for zebrafish Nrf2 to answer this question. We performed a
microarray analysis of zebrafish embryos that overexpressed
Nrf2, which was a different approach from previous reports
[19, 20]. The analysis revealed genes encoding proteasome
subunits and enzymes involved in glucose metabolism, sug-
gesting that the Nrf2-mediated regulation of both protein
turnover and glucose metabolism is evolutionarily conserved
among vertebrates.
2. Materials and Methods
2.1. Zebrafish and Chemical Treatments. The wild-type (AB)
and nrf2afh318 mutant [16] zebrafish strains were used in the
present study. The nrf2afh318 strain was maintained by PCR-
based genotyping, as described in Fuse et al. [17]. Embryos
were obtained by natural mating. For DEM treatment, the
larvae were placed in 3 cm culture dishes at 4 days post-
fertilization (dpf) and treated with 100𝜇M DEM for 6 h
(Wako, Osaka, Japan). All of the experiments were performed
according to methods that were approved by the Animal
Experiment Committee of the University of Tsukuba.
2.2. Microarray Analysis. A DNA microarray analysis was
performed using custom-made 16KMZH chips (GPL14379),
as described previously [19]. Biological experiments were car-
ried out in triplicate andmicroarray analyses were conducted
in duplicate or triplicate for each biological experiment. For
the overexpression of zebrafish nrf2a, capped nrf2a RNA was
synthesized from pCS2nrf2 [11] using an SP6 mMESSAGE
mMACHINE in vitro transcription kit (Ambion, Austin,
TX).One hundred pg ofmRNAwas injected into a 1-cell stage
embryo by an IM300 microinjector (Narishige, Tokyo,
Japan). At 8 h after injection, the embryos were collected
and homogenizedwithQIAzol reagent (Qiagen, Hilden, Ger-
many) and stored at −80∘C. A dual-color ratio methodology
was applied to compare nrf2a RNA-injected embryos with
uninjected embryos (Control), according to the manufac-
turer’s protocol for the AceGene DNA microarray (Hitachi
Solutions, Tokyo, Japan). Total RNA was extracted according
to the manufacturer’s instructions for QIAzol reagent (Qia-
gen), in combination with the clean-up protocol of the
RNeasy Mini Kit (Qiagen). Amino-allyl-modified RNA was
synthesized using the amino-allyl RNA amplification kit
(Sigma-Aldrich, St. Louis, MO) and labeled with monoreac-
tive Cy3 and Cy5 dyes (GE Healthcare, Little Chalfont, UK).
The hybridized MZH chips were scanned using the Affymet-
rix 428 array scanner (Affymetrix, Santa Clara, CA).Themic-
roarray data were processed from raw data image files with
Affymetrix Jaguar (Affymetrix) and were analyzed using per-
chip normalization. The processed data were subsequently
imported into Excel (Microsoft, Redmond, WA) to compare
expression profiles of two samples (injected versus unin-
jected with nrf2a mRNA). Genes whose expression was
affected by the Nrf2a overexpression were selected based on
cut-off values of >1.5-fold up or >1.5-fold down, without con-
sidering their significance. A biological pathway analysis was
performed using the Reactome database (http://www.react-
ome.org/). We have deposited the raw data at Gene Expres-
sion Omnibus (GEO) under accession number GSE86174,
and we can confirm all details are Minimum Information
About a Microarray Experiment compliant.
2.3. Real-Time PCR. Total RNA from nrf2a-overexpressing
embryos and DEM-treated larvae was prepared according to
the procedure that was performed in the microarray analysis.
cDNA was synthesized using ReverTra Ace qPCR RTMaster
Mix (Toyobo, Osaka, Japan) according to the manufacturer’s
instructions. A quantitative PCR (qPCR) was performed
using a 7500 Fast Real-Time PCR System (Thermo Fisher Sci-
entific, Waltham, MA) with THUNDERBIRD SYBR qPCR
Mix (Toyobo). The specific primers are listed in Table S1 in
Supplementary Material available online at http://dx.doi.org/
10.1155/2016/5720574. The expression level of each gene was
normalized to the level of ef1𝛼.
2.4. In Situ Hybridization Analysis. A whole-mount in situ
hybridization analysis was performed as described previ-
ously [21]. To construct pKSpsma3, pKSpsma5, pKSpsmb7,
pKSpgd, and pKSfbp1a, PCR fragments were amplified with
primers shown in Table S2 using cDNA synthesized from
zebrafish larvae (4 dpf), and ligated with pBluescript II
KS+ vector using a DNA Ligation Kit Ver.1 (Takara, Otsu,
Japan). Plasmids were linearized by restriction enzymes
(pKSpsma3, pKSpsmb7, and pKSpgd: BamHI; pKSpsma5:
EcoRI; pKSfbp1a: SpeI) and transcribed with T3 RNA poly-
merase (Roche Diagnostics, Indianapolis, IN) in the presence
of DIG RNA labeling mix (Roche Diagnostics) to make RNA
probes.The larvae were photographed using anMZ16 micro-
scope (Leica, Wetzlar, Germany) equipped with a DP73 digi-
tal camera (Olympus, Tokyo, Japan), followed by PCR-based
genotyping.
2.5. Statistical Analysis. The gene expression levels derived
from the real-time PCRs were compared using the two-tailed
Student’s 𝑡-test. 𝑃 values of <0.05 were considered to indicate
statistical significance.
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Table 1: The pathways activated in nrf2a-overexpressing embryos.
𝑝 value Pathway name Genes
5.27𝐸 − 7 Detoxification of reactive oxygen species txn, gstp1, prdx1, gsr, gpx1b, prdx5, gpx1a
5.22𝐸 − 5 Glutathione conjugation gclc, gsto2, gstp1, gclm, gsta.1
6.47𝐸 − 4 Reduction of cytosolic Ca++ levels atp2b2, calm3a
7.86𝐸 − 4 Apoptosis lmna, tradd, psma3, psmb7, psma5, tp53bp2a, kpna1, prkcdb
1.04𝐸 − 3 Programmed cell death lmna, tradd, psma3, psmb7, psma5, tp53bp2a, kpna1, prkcdb
5.09𝐸 − 3 Degradation of GLI1 by the proteasome tpk1, psma3, psmb7, psma5
5.09𝐸 − 3 GLI3 is processed to GLI3R by the proteasome tpk1, psma3, psmb7, psma5
5.09𝐸 − 3 Degradation of GLI2 by the proteasome tpk1, psma3, psmb7, psma5
5.99𝐸 − 3 Gluconeogenesis pcxb, fbp1a, pck1, tpk1
7.01𝐸 − 3 CaM pathway tpk1, calm3a, prkcdb
Bold genes encode proteasome subunits.
3. Results
3.1. The Identification of Novel Target Genes for Zebrafish Nrf2
by aMicroarray Analysis. To search for the novel target genes
of zebrafish Nrf2, we performed a microarray analysis of
zebrafish embryos overexpressing Nrf2. In vitro synthesized
mRNA of nrf2a, the functional ortholog of mammalian
Nrf2 in zebrafish, was injected into 1-cell stage of zebrafish
embryos, and the gene expression in the injected embryos
at 8 h after the injection was examined using 16KMZH
chips, which contain 16,399 probes [19]. In total, 115 genes
were found to be upregulated more than 1.5-fold by the
overexpression of nrf2a (Table S3).
The lineup of upregulated genes in the microarray of
nrf2a-overexpressing embryos was further analyzed using
the Reactome database to determine the biological func-
tions that could be influenced by these upregulated genes
(Table 1). Besides antioxidation and glutathione conjugation,
proteasome-related pathways were listed, due to the upreg-
ulation of the 3 genes encoding the proteasome subunits,
psma3, psma5, and psmb7 (proteasome subunits 𝛼3, 𝛼5, and
𝛽7, resp.). It should be noted that none of the genes encoding
the proteasome subunits, including these 3 genes, have been
identified in previous microarray analyses [19, 20].
3.2. Proteasome Subunits Were Regulated by Zebrafish Nrf2.
To validate the microarray results, we performed a real-
time qPCR. nrf2a-overexpressing embryos were prepared in
the same way as in the microarray analysis. Overexpression
of nrf2a in mRNA-injected embryos was confirmed by a
real-time qPCR (Figure S1, 75.5-fold higher compared to
uninjected embryos). As shown in Figure 1(a), psma3 was
significantly induced by the overexpression of nrf2a (1.51-
fold). psma5 and psmb7 also tended to be weakly induced by
the overexpression of nrf2a (1.28- and 1.18-fold, resp.). These
results suggest that, similarly to mammals [4], some of the
proteasome subunit genes are targets of Nrf2 in the zebrafish.
We then tested whether the expression of 3 proteasome
subunit genes is induced byDEM in anNrf2-dependentman-
ner by a real-time qPCR. AlthoughDEMdid not significantly
induce any of proteasome subunit genes at 6 h (Figure 1(b)),
psmb7 was induced after 12 h exposure (Figure 1(c)) in wild-
type larvae (1.59-fold) with statistical significance, while the
induction in nrf2afh318/fh318 mutant (1.33-fold) was weaker
than that of wild-type. psma3 and psma5 were also tended
to be induced after 12 h exposure to DEM both in wild-type
larvae (1.49- and 1.47-fold, resp.) and in nrf2afh318/fh318 mutant
larvae (1.27- and 1.63-fold, resp.).
We speculated that the reason of this unclear Nrf2-
dependencywas due to ubiquitous basal expression of protea-
some subunit genes. Thus, we next performed whole-mount
in situ hybridization to evaluate tissue-restricted induction of
the proteasome subunit genes, since many Nrf2 target genes
showed gill-, liver- or nose-specific induction in zebrafish
larvae [19]. As we expected, the expression of all three subunit
genes was induced in the liver of wild-type and heterozygous
mutant (nrf2afh318/+) larvae after 12 h exposure to DEM
(Figure 2). This liver-specific induction was not observed in
homozygous mutant siblings (nrf2afh318/fh318). These results
suggest that Nrf2 regulates the gene expression levels of
proteasome subunits in zebrafish, especially in the liver.
3.3. Zebrafish Nrf2 Regulates Enzymes That Are Involved in
Glucose Metabolism. It is noteworthy that many high-ranked
genes in the present microarray analysis were also identified
in the previous microarray analyses using DEM- or tBHQ-
treated larvae (see Table S3, gray highlighted genes) [19, 20].
This observation indicates that these 27 overlapping genes
may be strong candidates for zebrafish Nrf2 targets (Fig-
ure 3(a), indicated genes; Table S3, gray highlighted). We
therefore analyzed these genes using the Reactome database
to search for novel biological pathways that are related to
zebrafish Nrf2 (Table 2). As a result, the “Metabolism” path-
way was listed within the top 10 categories, in addition to the
pathways related to glutathione conjugation and antioxida-
tion. Three catabolic enzymes that are involved in glucose
metabolism were included in the “Metabolism” pathway:
pck1 (phosphoenolpyruvate carboxykinase 1), pcxb (pyruvate
carboxylase b), and pgd (phosphogluconate dehydrogenase).
Furthermore, looking back on the lineup of genes that were
upregulated by the overexpression of nrf2a (Table S3), two
more related genes were found: taldo1 (transaldolase 1) and
fbp1a (fructose-1,6-bisphosphatase 1a).
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Figure 1:The expression of the proteasome subunit genes. (a)The gene expression of the indicated proteasome subunits in 8 h postfertilization
(hpf) wild-type embryos injected with or without 100 pg of nrf2amRNA at the 1-cell stage was analyzed by a real-time qPCR. Total RNA was
extracted from 30 embryos for each sample. The expression of each gene was normalized to that of ef1𝛼 (means ± SEM), and the value in
uninjected control was set to 1. Asterisks denote statistical significance (Control versus nrf2a overexpression, ∗∗𝑃 < 0.01; Student’s 𝑡-test,
𝑛 = 6 for each group). (b) and (c)The gene expression of the indicated proteasome subunits in 4 dpf wild-type or nrf2afh318/fh318 mutant larvae
that were treated (or not treated) with 100𝜇M DEM for 6 h (b) and 12 h (c) was analyzed by a real-time qPCR. The expression of each gene
was normalized to that of ef1𝛼 (means ± SEM), and the value in untreated wild-type control was set to 1.
To confirm the Nrf2-dependent upregulation of these
genes, we next carried out a real-time qPCR using nrf2a-
overexpressing embryos.The result indicated that the expres-
sion levels of pgd and fbp1a (1.40- and 2.76-fold, resp.), but
not pck1, pcxb, and taldo1 (1.21-, 0.75-, and 0.70-fold, resp.),
were significantly upregulated by the overexpression of nrf2a
(Figure 3(b)). For pgd andfbp1a, we further analyzed the gene
expression in DEM-treated larvae. As shown in Figure 3(c),
the DEM treatment induced the expression of both pgd and
fbp1a in wild-type larvae (5.85- and 2.18-fold, resp.), and
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Figure 2: The induction profiles of proteasome subunit genes. Whole-mount in situ hybridization was performed to analyze the induction
profiles of psma3, psma5, and psmb7 using 4 dpf nrf2afh318 mutant larvae treated with or without 100𝜇M DEM for 12 h. The arrowheads
indicate positive expression in the liver, and asterisks denote the basal expression in the intestine. The numbers in each picture indicate the
positive/tested larvae.
the induction was weaker in homozygous nrf2afh318 mutant
larvae (2.15- and 1.20-fold, resp.), suggesting clear genetic
evidence of Nrf2-dependent regulation.
Induction profiles of these two genes were further
analyzed by in situ hybridization (Figure 4). In wild-type
and nrf2afh318 heterozygous mutant larvae, pgd was induced
specifically in the liver after treatment with DEM for 6 h,
while no induction was observed in nrf2afh318 homozygous
mutant. fbp1a was also induced by DEM in the liver, and
this induction was stronger in wild-type and heterozygous
mutant compared with homozygous mutant. Weak DEM-
induced expression of fbp1a was also observed in the gills,
but this inductionwas independent of nrf2a genotypes.These
results indicate that the Keap1-Nrf2 system, at least in part,
regulates the transcription of these enzymes involved in
glucose metabolism.
3.4.The Identification of Other Target Genes for ZebrafishNrf2.
The microarray data offered several more candidates for the
conserved Nrf2 target gene in zebrafish. We selected 6 genes
from the 27 overlapping genes (see Figure 3(a) and Table S3)
identified in the current and previous microarray analyses
and analyzed their expression using a real-time qPCR. The
genes that were selected included gclm (glutamate-cysteine
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Figure 3:The expression of glucose metabolism-related genes. (a)The upregulated gene lineups from the three microarray experiments were
compared. The data of DEM- or tBHQ-treated zebrafish larvae are from Nakajima et al. [19] and Hahn et al. [20], respectively. Numbers
in parentheses and in the Venn diagrams denote the numbers of genes which belong to each category. The names of 27 overlapping genes
were displayed. (b) The gene expression of the indicated enzymes related to glucose metabolism in 8 hpf wild-type embryos injected with or
without 100 pg of nrf2amRNA at the 1-cell stage was analyzed by a real-time qPCR. Asterisks denote statistical significance (Control versus
nrf2a overexpression, ∗𝑃 < 0.05; Student’s t-test, 𝑛 = 6 for each group). (c) The gene expression of the indicated enzymes related to glucose
metabolism in 4 dpf wild-type or nrf2afh318/fh318 mutant larvae treated with or without 100𝜇MDEM for 6 h was analyzed by a real-time qPCR.
Asterisks and hash marks denote statistical significance (DEM+ versus DEM−, ∗𝑃 < 0.05 and ∗∗𝑃 < 0.01; wild-type versus nrf2afh318/fh318,
#
𝑃 < 0.05; Student’s t-test, 𝑛 = 6 for each group).
ligase, modifier subunit), gsto2 (glutathione S-transferase
omega 2), gsr (glutathione reductase), sqstm1 (sequesto-
some 1), and keap1a (kelch-like ECH-associated protein 1a),
together with a well-studied nrf2a target, gstp1 (glutathione
S-transferase pi 1). As shown in Figure 5(a), gclm, gsto2 gsr,
and gstp1 were upregulated by the overexpression of nrf2a
(1.98-, 9.10-, 3.12-, and 6.39-fold, resp.), while sqstm1 and
keap1a were only slightly induced (1.28- and 1.21-fold, resp.).
The expression of these genes was further investigated in the
DEM-treated embryos (Figure 5(b)). All of the genes were
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Table 2: The pathways activated in both nrf2a-overexpressing embryos and DEM/tBHQ-treated larvae.
𝑝 value Pathway name Genes
3.33𝐸 − 9 Glutathione conjugation gclc, gsto2, gstp1, gclm, gsta.1
4.13𝐸 − 7 Phase II conjugation gclc, gsto2, gstp1, ugdh, gclm, gsta.1
7.44𝐸 − 7 Detoxification of reactive oxygen species txn, gstp1, prdx1, gsr
8.26𝐸 − 7 Biological oxidations gclc, gstp1, gsto2, aoc2, ugdh, gclm, gsta.1
1.39𝐸 − 3 Vitamin C (ascorbate) metabolism gsto2
1.78𝐸 − 3 Sulfur amino acid metabolism gclc, sqrdl, gclm
4.77𝐸 − 3 TP53 regulates metabolic genes txn, prdx1, gsr
6.76𝐸 − 3 Glutathione synthesis and recycling gclc, gclm
8.46𝐸 − 3 Cellular responses to stress txn, gstp1, prdx1, gsr
8.83𝐸 − 3 Metabolism gclc, pck1, gstp1, sqrdl, txn, gsta.1, gsr, pcxb, gsto2, aoc2, pgd, ugdh, gclm
Bold genes encode enzymes related to the glucose metabolism process.
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Figure 4: The induction profiles of glucose metabolism-related genes. Whole-mount in situ hybridization was performed to analyze the
induction profile of pgd andfbp1a using 4 pdf nrf2afh318 mutant larvae treated with or without 100 𝜇MDEM for 6 h. The arrowheads indicate
positive expression in the liver and gills, and asterisks denote the basal expression in the intestine. The numbers in each picture indicate the
positive expression in the liver/tested larvae.
strongly induced by DEM in wild-type larvae (gclm, 6.37-
fold; gsto2, 3.99-fold; gsr, 9.40-fold; gstp1, 5.88-fold; sqstm1,
5.44-fold; keap1a, 1.72-fold); the inductionwas weaker, except
for keap1a, in nrf2afh318/fh318 mutant larvae (gclm, 2.80-fold;
gsto2, 2.08-fold; gsr, 6.69-fold; gstp1, 1.94-fold; sqstm1, 2.35-
fold; keap1a, 2.10-fold). The results suggest that these genes
are target genes for zebrafish Nrf2.
In our microarray analysis, we also found 55 genes that
were downregulated by the overexpression of nrf2a (Table
S4). None of these genes, except hesx1, was identified in the
previous DEM- or tBHQ-based microarray analyses (25 and
82 genes, resp.) [19, 20]. More importantly, we could not find
genes associated with fatty acid metabolism or inflamma-
tion—recent studies have implied that these functions are
8 Oxidative Medicine and Cellular Longevity
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Figure 5: The expression of other candidate genes for zebrafish Nrf2 targets. (a) The expression of the indicated genes in 8 hpf wild-type
embryos injected with or without 100 pg of nrf2a mRNA at the 1-cell stage was analyzed by a real-time qPCR. Asterisks denote statistical
significance (Control versus nrf2a overexpression, ∗𝑃 < 0.05 and ∗∗𝑃 < 0.01; Student’s t-test, 𝑛 = 6 for each group). (b) The expression of
the indicated genes in 4 dpf wild-type or nrf2afh318/fh318 mutant larvae treated with or without 100 𝜇M DEM for 6 h was analyzed by a real-
time qPCR. Asterisks and hash marks denote statistical significance (DEM+ versus DEM−, ∗𝑃 < 0.05 and ∗∗𝑃 < 0.01; wild-type versus
nrf2afh318/fh318, #𝑃 < 0.05 and ##𝑃 < 0.01; Student’s t-test, 𝑛 = 6 for each group).
negatively regulated by Nrf2 [5, 22, 23]. The evolutional con-
servation related to the Nrf2-dependent negative regulation
of some types of genes remains unclear.
4. Discussion
In the present study, we found that the three proteasome sub-
units in the 20S core particle were regulated by zebrafishNrf2,
one of which (psmb7) has a trypsin-like protease activity;
the others (psma3 and psma5) comprise the 𝛼 ring structure
[24]. In mammals, multiple subunits of proteasome have also
been shown to be regulated by Nrf2 at the transcriptional
level [4], suggesting the presence of a conserved regulatory
mechanism among vertebrates. Consistent with the report by
Kwak et al. [4], which showed the transcriptional induction of
proteasome subunits in mice liver after treatment with D3T,
anNrf2-activating antioxidant, inductionwas observed dom-
inantly in the liver of zebrafish larvae. Although most Nrf2
Oxidative Medicine and Cellular Longevity 9
target genes tested in zebrafish larvae showed the induction
in the nose and gills in addition to the liver [19], proteasome
subunit genes were induced only in the liver. The molec-
ular basis of this liver specificity together with their slow
induction should be characterized in the future. As the Nrf2-
dependent upregulation of the proteasome function is sug-
gested to be important in the defense against oxidative stress,
endoplasmic reticulum stress, and senescence [25–27], it is
anticipated that the regulatory context should be clarified for
medical applications. The zebrafish model can also provide a
good model for further study.
Enzymes related to glucosemetabolismwere also targeted
by Nrf2 in zebrafish. Phosphogluconate dehydrogenase (Pgd)
is an enzyme that converts 6-phosphogluconate to ribulose 5-
phosphate in the oxidative branch of the pentose phosphate
pathway, which produces NADPH as well as purine nucleo-
tides [28]. The Nrf2-dependent upregulation of pgd has also
been demonstrated in mice [6]. The upregulation of pgdmay
confer protection against stressors by augmenting the supply
of NADPH, an essential cofactor for redox homeostasis [5],
and the activation of nucleotide biosynthesis through the
pentose phosphate pathway, which may lead to the metabolic
remodeling in cancer cells [6]. The zebrafish has recently
emerged as an important model in cancer biology [29, 30].
It will be worthwhile to study the Nrf2-dependent metabo-
lic remodeling that takes place in carcinogenesis using zeb-
rafish. In addition to pgd, the Nrf2-depedent transcriptional
regulation of fructose-1,6-bisphosphatase (Fbp), an enzyme
that converts fructose 1,6-bisphosphate to fructose 6-phos-
phate in gluconeogenesis, was observed specifically in the
liver. Further study on the mechanism underlying this liver-
specific induction will provide an important clue to under-
stand the biological significance of Nrf2-dependent regula-
tion of glucose metabolism.
In the present microarray analysis, the cut-off value for
significant upregulation by the overexpression of nrf2a was
set at a 1.5-fold change instead of a 2-fold change in the
previous studies [19, 20]. It was effective, since 4 out of 6
genes, as we validated the microarray data by a real-time
qPCR with statistical significance, showed less than 2-fold
change in the microarray analysis (see Figure S2 and Table
S3). A correlation in the fold changes betweenmicroarray and
real-time qPCRdatawas relatively poor; thus, it is worthwhile
to pick up not only high-ranked genes in the microarray
analysis but also low-ranked genes for further analyses.
The unique point of the present study is that genes
were screened using nrf2a-overexpressing embryos. A major
approach for the microarray-based screening of Nrf2-target
genes is the use of cells/tissues/animals treated with Nrf2-
activating compounds [31–33] as is the case for the previous
screen studies that used zebrafish [19, 20]. Another approach
is the use of Keap1 knockout cells/tissues [5, 34]. Since Keap1
is an E3 ubiquitin ligase that targets Nrf2, the disruption of its
gene increases the stability of Nrf2 and leads to the constitu-
tive activation of Nrf2. A study by Yates et al. [22] which com-
pared sets of genes upregulated by treatment with a potent
Nrf2-activating compound (CDDO-Im) with those upregu-
lated by liver-specific Keap1 knockout is of particular inter-
est. Keap1-knockout activated Nrf2-dependent transcription
more strongly than the pharmacological activation; as a result
greater numbers of Nrf2-regulated genes were detected [22].
It is possible that similar effects were observed in the over-
expression method of the present study.
5. Conclusions
In conclusion, we found novel Nrf2-target genes in zebrafish
by amicroarray analysis using nrf2a-overexpressing zebrafish
embryos. The basal expression levels of proteasome subunits
were revealed to be regulated by zebrafish Nrf2. In addition,
enzymes involved in the pentose phosphate pathway and
gluconeogenesis were found to be under Nrf2-dependent
transcriptional control. These results suggest that the Nrf2-
mediated regulation of the genes related to protein turnover
and glucose metabolism, at least a part of them, was evolu-
tionarily conserved in vertebrates.
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